AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Radiofrequency ablation being used to treat cancerous tumors.

Women's Health Weekly

| December 04, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 DEC 4 - (NewsRx.com & NewsRx.net) -- Radiofrequency ablation (RFA) is a minimally invasive procedure that is being used to treat certain cancers at The American Institute for Cancer Ablation.

A needle is inserted into the tumor using image guidance. RF energy is sent into the needle tip. The RF energy generates heat within the tumor. The heat results in the destruction of the treated tumor. This procedure is being used on certain lung, liver, bone, kidney. and breast tumors

Dr. Jason R. Williams, chief of cancer ablation at The American Institute for Cancer Ablation, has been using this procedure to treat many types of cancer. "We have seen great success with RFA," said Dr. Williams. "We have also had good results in treating larger tumors, particularly in the lungs," explained Dr. Williams.

RFA has generally been reserved for tumors under 4 cm. Doctors at The American Institute for Cancer Ablation have treated tumors up to 16 cm.

"It was previously felt that larger tumors could not be treated with RFA. We use sophisticated imaging techniques, such as combined PET/CT, to help guide our ...

Related articles from newspapers, magazines, journals, and more
Facial reconstruction techniques after skin cancer ablation are presented.
Newspaper article from: Biotech Week April 14, 2004 700+ words
...and colleagues published their study in Clinics in Plastic Surgery (Cheek and inferior eyelid reconstruction after skin cancer ablation. Clin Plast Surg, 2004;31(1):49). For more information, contact W.L. Murillo, Louisiana State University...
Focused ultrasound hones breast cancer ablation.(Women's Health)
Magazine article from: Family Practice News Jancin, Bruce April 1, 2007 700+ words
SAN ANTONIO -- Magnetic resonance-guided focused ultrasound shows great potential as a noninvasive means of ablating breast cancer, Dr. Yukiko Yasuda reported at a breast cancer symposium sponsored by the Cancer Therapy and Research Center. Indeed, results of a published phase II 30-patient trial
Misonix to Develop Laparoscopic Kidney Cancer Ablation Device Using HIFU With...
Press release article from: Business Wire April 25, 2001 700+ words
Business Editors & Health/Medical Writers FARMINGDALE, N.YBW HealthWireApril 25, 2001 Misonix Inc. (Nasdaq:MSON) today announced that it has exercised its right to the technology for a laparoscopic kidney tumor ablation device to be jointly developed with Focus Surgery Inc. Under the agreement,
Advanced Capabilities of BSD Medical's New Cancer Ablation System Unveiled at...
Press release article from: PR Newswire February 6, 2007 700+ words
SALT LAKE CITY, Feb. 6 /PRNewswire-FirstCall/ -- BSD Medical Corp. today announced that Paul F. Turner, Chief Technology Officer and Chairman of BSD Medical Corp., unveiled the advanced capabilities of BSD's new system designed for cancer tissue ablation, the MicroThermX 100, at the International
Celsion Receives FDA Approval for Phase I Breast Cancer Ablation Trials At Two...
Press release article from: Business Wire August 16, 1999 700+ words
COLUMBIA, MdBW HealthWireAug. 16, 1999-- -- Evaluation to be Accelerated via Studies to be Conducted at UCLA and Columbia (FL) -- Celsion Corp. (OTC BB:CELN) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to commence Phase I clinical studies at two
Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer...
Press release article from: PR Newswire December 17, 2007 700+ words
CAMBRIDGE, Mass., Dec. 17 /PRNewswire-FirstCall/ -- Genzyme Corp. announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental indication for Thyrogen(R) (thyrotropin alfa for injection) to be used in combination with radioiodine to ablate, or destroy, the remaining
Radiofrequency ablation being used to treat cancerous tumors.
Newspaper article from: Medical Devices & Surgical Technology Week December 7, 2003 700+ words
...cancers at The American Institute for Cancer Ablation. A needle is...ablation at The American Institute for Cancer Ablation, has been using...Doctors at The American Institute for Cancer Ablation have treated tumors...
Radiofrequency Ablation: A New Weapon in the Treatment of Cancer.
Press release article from: PR Newswire November 6, 2003 700+ words
...ablation at The American Institute for Cancer Ablation, has been using...Doctors at The American Institute for Cancer Ablation have treated tumors...CRNP of The American Institute for Cancer Ablation, +1-251...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA